Patritumab, CAS [[1262787-83-6]]

Produktübersicht

• Artikelname: Patritumab, CAS [[1262787-83-6]]
• Artikelnummer: MCE-HY-P99275
• Hersteller Artikelnummer: HY-P99275
• Alternativnummer: MCE-HY-P99275-1MG,MCE-HY-P99275-5MG,MCE-HY-P99275-50MG,MCE-HY-P99275-10MG,MCE-HY-P99275-25MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: Human Anti-ERBB3 Recombinant Antibody, AMG-888, U3-1287

Produktbeschreibung

Patritumab (Human Anti-ERBB3 Recombinant Antibody) is a neutralizing monoclonal antibody to ERBB3. Patritumab shows a synergy with Cetuximab (HY-P9905), potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors[1].

Produkteigenschaften

• Molekulargewicht: (146.86 kDa)
• Reinheit: 99.28
• CAS Nummer: [1262787-83-6]
• Target-Kategorie: Akt,EGFR,ERK,PARP,Survivin

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies